HS-CRP: High Sensitivity CRP (C-reactive Protein)
WEBC-reactive protein (CRP) is an acute-phase protein produced in the liver as part of the body’s natural inflammatory response. 1,2 It is produced in greater volumes when inflammatory conditions are present, with high concentrations indicating more serious inflammation of the patient’s system. 1 CRP tests, which measure the concentration of CRP in blood plasma, are a useful non-specific ...
Hypertensive Crisis, Urgency, & Emergency - The Cardiology Advisor
WEBUpdated: 05/20/2024. A hypertensive crisis is a severe increase in blood pressure (systolic ≥180 mm Hg and/or diastolic ≥110 mm Hg). 1 Without immediate intervention, severe cases can be fatal. 1 There are 2 types of hypertensive crises: hypertensive urgency and hypertensive emergency. 1 A hypertensive urgency is a severe elevation in blood pressure in an otherwise stable patient who does ...
FFR: Fractional Flow Reserve - The Cardiology Advisor
WEBDec 5, 2022 · FFR Definition & Description. FFR is defined as ratio of pressure measured in coronary segment distal to stenosis (Pd) and pressure measured proximal to stenosis, usually aortic pressure (Pa) or pressure measured in healthy proximal coronary segment. Fractional flow reserve formula is FFR = Pd/Pa. 3 FFR …
Congestive Heart Failure Symptoms, Stages, & Classification - The ...
WEBFeb 13, 2024 · Congestive heart failure is a potentially life-threatening condition that impacts millions of people. However, patients with congestive heart failure may be asymptomatic until functional remodeling of the heart occurs. 1 In addition, heart failure is often overlooked or misdiagnosed, particularly in older adults. 2 To help health care providers increase patient awareness, this article covers ...
Cardiology News, Research Articles | Heart Disease, Disorder Studies
WEBRethinking Beta-Blocker Use Following Acute Myocardial Infarction. By Tori Rodriguez, MA, LPC, AHC. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.
Antianginal Drugs - The Cardiology Advisor
WEBNov 17, 2022 · Antianginal Drugs in Summary. Angina is chest pain or chest discomfort due to an imbalance between myocardial oxygen supply and demand. 1,2 Angina is a predictor of future cardiovascular events; therefore, angina treatment goals are to prevent myocardial infarction (MI) and death, and to alleviate symptoms of angina. 1-3 …
Comparison of Risk Associated With STEMI vs NSTEMI
WEBSep 7, 2016 · Rehospitalization rates for MI and stroke as well as the composite end point between STEMI and NSTEMI patients were as follows: 6.1% vs 9.6% (P <.001), 2.7% vs 3.2% (P =.006), and 21.9% vs 27.9% (P <.001). The unadjusted rates of all end points were lower for STEMI patients compared with NSTEMI patients from 90 days to 2 years.
Beta Blockers in Heart Failure Management - The Cardiology Advisor
WEBFeb 12, 2024 · Beta blockers are the mainstay heart failure treatment for patients with an LVEF of up to 40%, as seen in HFrEF. 2 High-quality evidence from multiple RCTs indicates that beta blockers can boost clinical status by improving left ventricular function and reducing symptoms of heart failure, and the risk of hospitalization and mortality. 2 In ...
How Long to Discontinue Apixaban for Optimal Concentration …
WEBDecember 30, 2021. Patients achieved optimal serum apixaban levels when discontinuing use 60 hours or more prior to invasive or major surgery, according to clinical trial results published in Vascular Medicine. Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS) (ClinicalTrials.gov Identifier: NCT02935751) was a single ...
Glycoprotein IIb/IIIa Inhibitors - The Cardiology Advisor
WEBNov 17, 2022 · Presentation and Cause. Glycoprotein IIb/IIIa inhibitors are a class of drugs that prevent the binding of fibrinogen to platelets. This class of drugs includes abciximab, eptifibatide, and tirofiban. 1 Glycoprotein IIb/IIIa inhibitors are approved by the FDA to treat acute coronary syndromes (ACS) including unstable angina and non-ST elevation myocardial infarction that needs percutaneous ...